The COVID-19 test kit is used for the qualitative detection via multiplex real-time PCR of 2019-nCoV specific RNA in nasopharyngeal swab samples. A positive test result from the test may indicate the presence of 2019-nCoV specific RNA in the test sample. There is no cross-reactivity with SARS, influenza A H1N1, influenza A H3N2, influenza B, or MERS. “In terms of clinical sensitivity, the COVID-19 test kit has been able to detect 100 percent of the positive samples tested, with no false positive and negatives reported”.

At Santé we are  fearless  / global  /  agile  / QUALITY assured  /  proven
About Santé